Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) has shown a notable financial event with the receipt of the payment from Scilex. To further understand Oramed's financial health and future prospects, key metrics and InvestingPro Tips can provide valuable insights. With a market capitalization of $93.45 million and holding more cash than debt, Oramed appears to have a solid balance sheet. However, analysts are forecasting a sales decline in the current year, and they do not expect the company to be profitable within this timeframe.